Clinical trial
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients…
NCT00459069 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00459069 |
|---|---|
| Title | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma |
| Official title | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Dana-Farber Cancer Institute Brigham and Women's Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological |
| Interventions | Dendritic Cell Tumor Fusion Vaccine |
| Enrollment | 18 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Apr 11, 2007 |
| Last update posted | Jan 12, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: